Ace the Case: A 42-Year-Old Woman With Anemia and Elevated Serum Total Protein

Access Activity

Overview / Abstract:

This educational activity will utilize a case study to discuss minimal residual disease measurement and treatment options for newly diagnosed multiple myeloma patients who are eligible for autologous stem cell transplant (ASCT).

Expiration

Sep 22, 2021

Discipline(s)

Clinical Laboratory CE, Nursing CNE, Physician CME, Physician Assistant CME

Format

Monograph, Online

Credits / Hours

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Penn State College of Medicine, RedMedEd, and the Multiple Myeloma Research Foundation. Penn State College of Medicine is accredited by the ACCME to provide continuing medical education for physicians. Penn State College of Medicine designates this enduring material for 0.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Successful completion of this CME activity enables the participant to earn 0.25 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants who opt in will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to the ACCME for the purpose of granting ABIM MOC points.

Accreditation

ACCME, ABIM MOC points

Is This Activity Certified for "Live" Credit?

YES

Presenters / Authors / Faculty

Faith E. Davies, MBBCh, MD
Director, Clinical Myeloma Program
Laura & Isaac Perlmutter Cancer Center at New York University
Langone Health
New York, New York

Activity Specialities / Related Topics

Education / Teaching, Hematology, Oncology / Cancer / Radiation Therapy

Sponsors / Supporters / Grant Providers

Support for this activity has been provided through educational grants from Adaptive Biotechnologies; Amgen; Bristol Myers Squibb; Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC; Karyopharm Therapeutics; Oncopeptides; and Sanofi Genzyme.

Keywords / Search Terms

RedMedEd RedMedEd RedMedEd, MMRF, PSCM, multiple myeloma, MM, risk, case study, free, CME, oncology, high-risk, hematologist, oncologist, patients, myeloma, smoldering myeloma, smoldering, free, CME, CE Free CE CME Live CE CME Free CE CME Live CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map